XML 20 R4.htm IDEA: XBRL DOCUMENT v3.21.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Sep. 30, 2021
Sep. 30, 2020
Current Assets    
Cash and equivalents $ 2,283 $ 2,825
Restricted cash 109 92
Short-term investments 12 20
Trade receivables, net 2,497 2,398
Inventories 2,866 2,743
Prepaid expenses and other 1,072 891
Total Current Assets 8,838 8,969
Property, Plant and Equipment, Net 6,393 5,923
Goodwill 23,901 23,620
Developed Technology, Net 9,417 10,146
Customer Relationships, Net 2,818 3,107
Other Intangibles, Net 548 560
Other Assets 1,952 1,687
Total Assets 53,866 54,012
Current Liabilities    
Short-term debt 500 707
Accounts payable 1,793 1,355
Accrued expenses 2,943 2,638
Salaries, wages and related items 1,214 993
Income taxes 176 144
Total Current Liabilities 6,626 5,836
Long-Term Debt 17,110 17,224
Long-Term Employee Benefit Obligations 1,228 1,435
Deferred Income Taxes and Other Liabilities 5,225 5,753
Commitments and Contingencies (See Note 5)
Shareholders’ Equity    
Preferred stock 2 2
Common stock — $1 par value: authorized — 640,000,000 shares; issued — 364,639,901 shares in 2021 and 2020. 365 365
Capital in excess of par value 19,272 19,270
Retained earnings 13,826 12,791
Deferred compensation 23 23
Common stock in treasury — at cost — 80,163,949 shares in 2021 and 74,622,657 shares in 2020. (7,723) (6,138)
Accumulated other comprehensive loss (2,088) (2,548)
Total Shareholders’ Equity 23,677 23,765
Total Liabilities and Shareholders’ Equity $ 53,866 $ 54,012
Common stock, par value (USD per share) $ 1 $ 1
Common stock, shares authorized (shares) 640,000,000 640,000,000
Common stock, shares issued (shares) 364,639,901 364,639,901